Press "Enter" to skip to content

Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data

FDA provides updates to postmarketing studies that agency ordered three manufacturers of duodenoscopes to conduct to assess bacterial contamination of devices.

Original source:

Also Read:   FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots